What Researchers Did
The authors describe the plan for a large trial that will test whether hyperbaric oxygen helps prevent bone damage in the jaw when patients who have had radiotherapy need a high-risk dental procedure.
What They Found
This paper is a protocol for a phase III, multi-centre randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible, and it reports no patient results. Eligible patients need a high-risk dental procedure in the mandible and must have received at least 50-Gy radiotherapy. They are randomised 1:1 to a hyperbaric oxygen arm (Marx protocol) or a control arm, and both groups receive antibiotics and chlorhexidine mouthwash. The primary endpoint is osteoradionecrosis at 6 months after surgery. Secondary endpoints include other time points, acute symptoms and pain, quality of life, and implant retention where implants are placed. The authors state that the evidence for hyperbaric oxygen remains poor and that current practice varies greatly.
What This Means for Canadian Patients
This paper gives no results, so it cannot show whether hyperbaric oxygen prevents osteoradionecrosis after dental surgery in a previously irradiated jaw. The abstract says the evidence for its use is poor and practice varies. Patients facing a dental extraction or implant after head and neck radiotherapy should talk with their care team about their own options.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a protocol, the paper has no outcome data, and the trial is unblinded, although a blinded expert panel will assess the primary endpoint using anonymised photographs and radiographs.